Safety and Immunogenicity of a Fourth Dose of Omicron BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18-55 Years Old. (academic.oup.com)

Authors: Winokur P … Kitchin N Journal: Clinical Infectious Diseases Published: 2026-05-20 DOI: https://doi.org/10.1093/cid/ciag026